Watch AAQL. Know when insiders buy.
One email the day a filing lands. Free.
AAQL
Antiaging Quantum Living Inc.
0.58
+0.00 +0.00%
USD · close Sep 4
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
—
not graded: no insider, short or call data yet
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $19.9MP/E —DIV YIELD —FCF YIELD —REV TTM $1.5M +62.4%NET INCOME −$1MNET CASH —52W 0.55 – 1.06SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2027 · Jun 30 | $730K | +150.5% | 42.9% | −$323K | −$319K | — | -0.01 | −$472K | — | — | Aug 14 |
| Q4 2026 · Mar 31derived | $12K | −95.7% | -488.3% | −$374K | −$371K | — | -0.01 | −$426K | — | — | Jul 14 |
| Q3 2026 · Dec 31 | $340K | +120.3% | 59.9% | −$272K | −$272K | — | -0.01 | $346K | — | — | Feb 13 |
| Q2 2026 · Sep 30 | $390K | +125.3% | 83.2% | −$51K | −$62K | — | -0.00 | $93K | — | — | Feb 13 |
| Q1 2026 · Jun 30 | $291K | +44.2% | 80.5% | −$138K | −$133K | — | -0.00 | −$185K | $1K | −$186K | Aug 14 |
| Q4 2025 · Mar 31derived | $288K | — | -28.3% | −$179K | −$180K | — | -0.01 | −$333K | — | — | Jul 14 |
| Q3 2025 · Dec 31 | $154K | +2352.3% | 96.7% | −$199K | −$129K | — | -0.00 | −$344K | — | — | Feb 13 |
| Q2 2025 · Sep 30 | $173K | — | 91.7% | −$198K | −$198K | — | -0.01 | −$9K | — | — | Feb 13 |
| Q1 2025 · Jun 30 | $202K | — | 99.9% | −$214K | −$214K | — | -0.01 | −$214K | — | — | Feb 13 |
| Q4 2024 · Mar 31derived | $0 | — | — | −$262K | −$262K | — | -0.01 | −$135K | — | — | Jul 2 |
| Q3 2024 · Dec 31 | $6K | — | 87.9% | −$97K | −$97K | — | -0.00 | −$454K | — | — | Feb 19 |
| Q2 2024 · Sep 30 | $0 | — | — | −$24K | −$24K | — | -0.00 | −$32K | — | — | Feb 19 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2026 · to Mar 31 | $1M | 67.9% | −$835K | −$838K | -81.0% | -0.03 | −$171K | — | — | — | — |
| FY2025 · to Mar 31 | $818K | 52.4% | −$790K | −$720K | -88.1% | -0.02 | −$900K | — | — | — | — |
| FY2024 · to Mar 31 | $7K | 89.7% | −$413K | −$413K | -5507.0% | -0.01 | −$649K | — | — | — | — |
| FY2023 · to Mar 31 | $14K | 100.0% | −$37K | −$37K | -269.3% | -0.00 | −$38K | — | — | — | — |
| FY2022 · to Mar 31 | $7K | 85.1% | −$45K | −$43K | -587.0% | -0.00 | −$41K | $950 | −$42K | — | — |
| FY2021 · to Mar 31 | $4K | 78.9% | −$73K | −$67K | -1750.3% | 0.00 | −$64K | — | — | — | — |
Every number comes from Antiaging Quantum Living Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.